A bioactive peptide that combines glucagon with the thyroid hormone T3 lowers lipid levels, improves glucose tolerance, and promotes energy expenditure to treat symptoms and underlyingcauses of metabolic disease. The two active components both maximize their combined benefitsand mitigate the negative consequences of treatment with each alone